Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck to buy virus-based cancer drug firm Viralytics for $394 million
Merck to buy virus-based cancer drug firm Viralytics for $394 million
Merck to buy virus-based cancer drug firm Viralytics for $394 million
Submitted by
admin
on February 21, 2018 - 11:04pm
Source:
Reuters
News Tags:
Merck
Viralytics
M&A
cancer
Headline:
Merck to buy virus-based cancer drug firm Viralytics for $394 million
Do Not Allow Advertisers to Use My Personal information
